Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's LymphomaCraig H. Moskowitz, Andrew D. Zelenetz, Joseph R. Bertino et al.|Journal of Clinical Oncology|1999Cited by 303
Future cancer research priorities in the USA: a Lancet Oncology CommissionElizabeth M. Jaffee, Richard Sullivan, Sangeeta N. Bhatia et al.|The Lancet Oncology|2017Cited by 209
Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapiesIsett Laux, David B. Agus|British Journal of Cancer|2005Cited by 69
HER Kinase Axis Receptor Dimer Partner Switching Occurs in Response to EGFR Tyrosine Kinase Inhibition despite Failure to Block Cellular ProliferationAnjali Jain, David B. Agus|Cancer Research|2010Cited by 67